Serbian opposition lawmakers threw smoke grenades and tear gas inside parliament on Tuesday to protest against the government ...

Notably, off-label tenecteplase had already become the preferred thrombolytic for acute ischemic stroke before the expanded ...

South Shore University Hospital's stroke support group meets monthly to offer hope and understanding to survivors and care ...

Women with one or more gynecological disorders had higher risk of heart disease and clogged arteries affecting either their ...

Popovich has not coached since suffering what the Spurs described as a “mild stroke” on Nov. 2. His status for next season is ...

San Antonio Spurs coach Gregg Popovich announces he will not return to the sidelines this season after he suffered a mild ...

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

A new Georgetown University Medical Center study exploring a new brain imaging technique is bringing stroke experts a step ...

Stroke is a leading cause of death and disability worldwide, making early diagnosis and intervention critical. In a recent ...

Discover how hypertension, diabetes, atrial fibrillation, high cholesterol, and obesity increase stroke risk, and learn ...

Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...

In 2023, Roche said it was removing TNKase for stroke from its phase 3 programmes after a readout of the TIMELESS trial, but ...